Schizophrenia: One Coat of Many Colors
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Lisboa S, Gomes F, Silva A, Uliana D, Camargo L, Guimaraes F Int J Neuropsychopharmacol. 2015; 18(8).
PMID: 25618404 PMC: 4571624. DOI: 10.1093/ijnp/pyv005.
References
1.
Dong E, Agis-Balboa R, Simonini M, Grayson D, Costa E, Guidotti A
. Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia. Proc Natl Acad Sci U S A. 2005; 102(35):12578-83.
PMC: 1194936.
DOI: 10.1073/pnas.0505394102.
View
2.
Yao J, Reddy R, McElhinny L, VAN KAMMEN D
. Effects of haloperidol on antioxidant defense system enzymes in schizophrenia. J Psychiatr Res. 1998; 32(6):385-91.
DOI: 10.1016/s0022-3956(98)00028-4.
View
3.
Leng A, Feldon J, Ferger B
. Long-term social isolation and medial prefrontal cortex: dopaminergic and cholinergic neurotransmission. Pharmacol Biochem Behav. 2004; 77(2):371-9.
DOI: 10.1016/j.pbb.2003.11.011.
View
4.
Banigan M, Kao P, Kozubek J, Winslow A, Medina J, Costa J
. Differential expression of exosomal microRNAs in prefrontal cortices of schizophrenia and bipolar disorder patients. PLoS One. 2013; 8(1):e48814.
PMC: 3559697.
DOI: 10.1371/journal.pone.0048814.
View
5.
Ayalew M, Le-Niculescu H, Levey D, Jain N, Changala B, Patel S
. Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Mol Psychiatry. 2012; 17(9):887-905.
PMC: 3427857.
DOI: 10.1038/mp.2012.37.
View